XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, net income was USD 0.221 million compared to net loss of USD 0.865 million a year ago.
1st Jan change | Capi. | |
---|---|---|
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |